Related Experiment Video
Updated: Jan 17, 2026

Evaluation of T Follicular Helper Cells and Germinal Center Response During Influenza A Virus Infection in Mice
Published on: June 27, 2020
Trefoil factor 2 interacts with A4GNT to regulate inflammation to protect against pneumonia during influenza virus
Weihui Fu1, Jun Fan1, Tianyun Peng1
1Shanghai Public Health Clinical Center, Zhongshan Hospital, Institutes of Biomedical Sciences, Fudan University, Shanghai, China.
Abstract:
Trefoil factor 2 (TFF2) has been shown to reduce inflammation and promote mucosal repair in models of gastric and colonic injury. However, the role of TFF2 in acute respiratory tract infection remains elusive. Here, we demonstrate that TFF2 protects mice against pneumonia in influenza virus infections. In vitro studies have revealed that TFF2 does not directly bind to the previously reported potential receptors but recognizes the terminal GlcNAc-α-1,4-Gal disaccharide of cell surface proteins mediated by the glycosyltransferase activity of α1,4-N-acetylglucosaminyltransferase (A4GNT). Functionally, TFF2 organized membranous TFF2-A4GNT-glycan protein complex serves to restrain cellular inflammation pathways by augmenting inhibitory Tyr527 phosphorylation at the C-terminus of Src-family kinases (SFKs), thereby effectively preventing the phosphorylation of stimulatory SFKs Tyr416. Finally, we have conclusively verified that the protective effect of TFF2 relies on the TFF2-A4GNT-glycan axis during influenza virus infection. In the future, TFF2 may offer a potential intervention strategy for acute respiratory inflammatory diseases.
Insights
Trefoil factor 2 (TFF2) protects mice from pneumonia during influenza virus infection. This protective effect involves TFF2 binding to cell surface glycans via A4GNT, restraining inflammation and offering potential for respiratory disease treatments.
Area of Science:
- Immunology
- Molecular Biology
- Virology
Background:
- Trefoil factor 2 (TFF2) is known for its anti-inflammatory and mucosal repair properties in the gastrointestinal tract.
- The role of TFF2 in acute respiratory tract infections, particularly influenza, is not well understood.
Purpose of the Study:
- To investigate the protective role of TFF2 in mouse models of influenza virus-induced pneumonia.
- To elucidate the molecular mechanism by which TFF2 exerts its protective effects.
Main Methods:
- Influenza virus infection model in mice.
- In vitro binding assays to identify TFF2 receptors.
- Analysis of signaling pathways, including Src-family kinases (SFKs) phosphorylation.
- Investigation of the TFF2-A4GNT-glycan complex.
Main Results:
- TFF2 administration protected mice against pneumonia caused by influenza virus infection.
- TFF2 binds to cell surface glycans through α1,4-N-acetylglucosaminyltransferase (A4GNT) activity, not previously identified receptors.
- TFF2 forms a complex that restrains inflammation by augmenting inhibitory Src-family kinases (SFKs) phosphorylation (Tyr527) and preventing stimulatory phosphorylation (Tyr416).
Conclusions:
- The protective effect of TFF2 against influenza pneumonia is mediated by the TFF2-A4GNT-glycan axis.
- TFF2 represents a potential therapeutic target for acute respiratory inflammatory diseases.
More Related Videos
09:56Intra-tracheal Administration of Haemophilus influenzae in Mouse Models to Study Airway Inflammation
Published on: March 2, 2016
12:21A Mouse Model for the Transition of Streptococcus pneumoniae from Colonizer to Pathogen upon Viral Co-Infection Recapitulates Age-Exacerbated Illness
Published on: September 28, 2022
Related Concept Videos
Leaky Scanning
Pneumonia II: Pathophysiology
GPCRs Regulate Adenylyl Cylase Activity
Gene Regulation in Microbial Communities: Quorum Sensing